Inventor

HAYAKAWA ICHIRO

JP11 patents

⚠️ This page may combine multiple inventors who share the name “HAYAKAWA ICHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAIICHI SANKYO CO LTD

7 patents

US10155821B2Dec 18, 2018

Anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD17 citations94

US11795236B2Oct 24, 2023

Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD6 citations85

US11584800B2Feb 21, 2023

Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD2 citations73

US12246196B2Mar 11, 2025

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines

DAIICHI SANKYO CO LTD1 citations72

US11628223B2Apr 18, 2023

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines

DAIICHI SANKYO CO LTD1 citations71

US11583590B2Feb 21, 2023

Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor

DAIICHI SANKYO CO LTD1 citations71

US12350344B2Jul 8, 2025

Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate

DAIICHI SANKYO CO LTD0 citations60

SANKYO CO

4 patents

US6040339AMar 21, 2000

Urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use

SANKYO CO53 citations94

US5880147AMar 9, 1999

Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use

SANKYO CO34 citations91

US5614550AMar 25, 1997

Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses

SANKYO CO19 citations91

US5534529AJul 9, 1996

Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses

SANKYO CO14 citations72